Listed by the USPTO as JONES, CHRISTINE MICHELLE
Tech Center 1600 • Art Units: 1634 1682
This examiner grants 0% of resolved cases
JONES, CHRISTINE MICHELLE is assigned to tech center 1600 and art unit 1634. The profile contains 1 resolved case, an allowance rate of 0.0%, and a median of 1067 days to allowance. The interview lift is 0.0%, so the single recorded matter does not show an interview-related change in outcome.
The one-case record is too limited to establish a reliable examiner pattern. It does support conservative prosecution planning, including careful preparation for the first action and attention to timing. Listed companies are Illumina Inc., Robert Bosch GmbH, and The Board of Trustees of the Leland Stanford Junior University. Listed firms are Sheppard, Mullin, Richter & Hampton LLP, SUGHRUE MION, PLLC, and Sullivan & Worcester LLP.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18634263 | SEQUENCING BY SYNTHESIS USING ELECTROACTIVELY LABELED 3-OH-MODIFIED NUCLEOTIDES | Non-Final OA | Robert Bosch GmbH |
| 18561259 | Next-Generation Volumetric in Situ Sequencing | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 17580364 | MICROFLUIDIC DEVICE FOR SARS-COV-2 DETECTION AND METHOD USING THE SAME | Final Rejection | National Tsing Hua University |
| 18279769 | METHODS AND DEVICES FOR NUCLEIC ACID DETECTION | Final Rejection | The Regents of the University of Colorado, a Body Corporate |
| 18458354 | REACTION COMPOSITION FOR NUCLEIC ACID AMPLIFICATION AND NUCLEIC ACID AMPLIFICATION METHOD USING SAME | Non-Final OA | NOF CORPORATION |
| 18710724 | SYSTEMS AND METHODS FOR NUCLEIC ACID EXTRACTION AND VISUAL DETECTION | Non-Final OA | UNIVERSITY OF CONNECTICUT |
| 18564575 | ENZYME FORMULATIONS AND REACTION MIXTURES FOR NUCLEIC ACID AMPLIFICATION | Final Rejection | Gen-Probe Incorporated |
| 18692623 | DETECTION OF TARGET NUCLEIC ACID SEQUENCE BY USING SYNTHETIC NON-NATURAL BASE-BEARING TAG OLIGONUCLEOTIDE | Non-Final OA | SEEGENE, INC. |
| 18506147 | Method for detection of single nucleotide variant | Final Rejection | KAOHSIUNG MEDICAL UNIVERSITY |
| 18534113 | FLOW CELLS AND SEQUENCING KITS | Final Rejection | ILLUMINA, INC. |
| 18476052 | METHODS OF MODULATING CLUSTERING KINETICS | Final Rejection | Illumina, Inc. |
| 18475939 | Amplification Compositions and Methods | Final Rejection | Illumina, Inc. |
| 18563211 | IMPROVEMENTS IN OR RELATING TO DIGESTION OF REACTION PRODUCTS | Final Rejection | LumiraDx UK Ltd. |
| 17576972 | LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) ANALYSIS FOR PATHOGENIC TARGETS | Non-Final OA | Raytheon BBN Technologies, Corp. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy0.0% of resolved applications examined by Christine Michelle Jones were allowed (1 resolved cases), compared with 30.4% across Art Unit 1634 over the last five years.
This examiner's interview lift is +0.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Christine Michelle Jones took 1,067 days on average from filing to allowance.
Christine Michelle Jones examines applications in Art Unit 1634 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
